FIELD: medicine, oncology, pharmacology. SUBSTANCE: invention proposes an agent that is a stable heavy oxygen isotope of the formula 18O at its concentration in medium 15%, not less. EFFECT: enhanced effectiveness of agent. 4 tbl
Title | Year | Author | Number |
---|---|---|---|
MEANS TO INHIBIT TUMOR GROWTH | 1995 |
|
RU2106146C1 |
MEDIUM WITH ANTI-TUMOUR EFFECT AND METHOD OF ITS OBTAINMENT | 2007 |
|
RU2349317C1 |
METHOD FOR INCREASING IMMUNOGENICITY OF WHOLE-CELL ANTI-CANCER VACCINE | 2010 |
|
RU2458120C1 |
HUMAN T-LYMPHOBLASTIC LEUCEMIA A4 CELL LINE USEFUL IN SCREENING OF ANTITUMOR AGENTS | 2004 |
|
RU2267532C1 |
INDOLOCARBAZOLE DERIVATIVE BLOCKING TUMOUR VASCULOGENIC MIMICRY | 2014 |
|
RU2557554C1 |
METHOD OF QUALITATIVELY AND QUANTITATIVELY DETERMINING, IN COMPLEX MIXTURES AND EXTRACTS, NITRO DERIVATIVES OF POLYCYCLIC AROMATIC HYDROCARBONS PHOSPHORESCING IN FROZEN SOLUTIONS | 1997 |
|
RU2122199C1 |
METHOD FOR PREPARING ACTIVATED MONONUCLEAR LEUKOCYTES | 2009 |
|
RU2402338C1 |
METHOD OF DETERMINING THE ABILITY OF CELLS TO SECRETE PROSTAGLANIN E TO CULTIVATION MEDIUM | 0 |
|
SU1529125A1 |
APPLICATION OF TRIINDOLYL METHANE DERIVATIVES AS ANTICANCER DRUGS | 2010 |
|
RU2454232C2 |
POLYPEPTIDES FOR TREATING ONCOLOGICAL DISEASES | 2017 |
|
RU2728870C2 |
Authors
Dates
1997-11-10—Published
1996-12-25—Filed